Has Sana Ali, MD received payments from drug or device companies?

Yes. Drug and device makers reported $457 in general payments to Sana Ali, MD across 17 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sana Ali, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sana Ali, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sana Ali, MD

Neuroradiology · Valhalla, NYNPI 1619268448

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Merck at 27.6% of the total. That places this record below the midpoint for neuroradiology clinicians in NY, where the typical reported total is $374.

$457in general payments, 2019–2025

Across 17 payments — averaging $26.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$126
Regeneron Healthcare Solutions, Inc.$96
CSL Behring$93
Johnson & Johnson$48
Alcon$45
Coherus Oncology, Inc.$27
plus $22 from 1 others

What the payments were for

Food & beverage$457100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	5	$126
Regeneron Healthcare Solutions, Inc.	2	$96
CSL Behring	4	$93
Johnson & Johnson	2	$48
Alcon	2	$45
Coherus Oncology, Inc.	1	$27
ANI Pharmaceuticals, Inc.	1	$22

How this compares

$457 in reported general payments places this provider in the 50th percentile of 71 neuroradiology providers in New York.

See all neuroradiology providers in New York →

Medicare billing

Part B allowed, 2024

$109,041

Medicare patients

1,028

Services billed

9,716

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neuroradiology in Valhalla

Javin ScheffleinValhalla$168
Hasit MehtaValhalla$158
David FiorellaStony Brook$1.3M
Peter NelsonNew York$918K
Eytan RazNew York$605K
Maksim ShapiroNew York$279K
Hediyeh BaradaranNew York$146K
Ana FranceschiManhasset$125K
Gagandeep SinghNew York$70K
Rafael OrtizNew York$40K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →